Eris Lifesciences acquires trademark Zomelis (for Vildagliptin) from Novartis AG for India market EP News Bureau Dec 4, 2019 Zomelis is used in the treatment of type 2 diabetes and comes under a new class of anti-diabetic drugs known as DPP 4 inhibitors
‘Our aim is to enable Indian physicians to stay connected with global developments’ Usha Sharma Aug 12, 2019 Eris Lifesciences recently entered into a partnership with PlexusMD to launch Saarthi, an interactive learning platform for…
Eris Lifesciences and PlexusMD join hands to offer ‘Saarthi’ EP News Bureau Jul 1, 2019 'Saarthi' is a unique AI-powered online learning platform for doctors in India
